دورية أكاديمية
أعرض في EDS

Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury.

التفاصيل البيبلوغرافية
العنوان: Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury.
المؤلفون: Sosnovtseva AO; Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Moscow, Russia., Stepanova OV; Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Moscow, Russia.; Department of Neurohumoral and Immunological Research, National Medical Research Center of Cardiology, The Ministry of Health of the Russian Federation, Moscow, Russia., Stepanenko AA; Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Moscow, Russia.; Department of Medical Nanobiotechnology, Institute of Translational Medicine, N.I. Pirogov Russian National Research Medical University, The Ministry of Health of the Russian Federation, Moscow, Russia., Voronova AD; Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Moscow, Russia., Chadin AV; Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Moscow, Russia., Valikhov MP; Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Moscow, Russia.; Department of Neurohumoral and Immunological Research, National Medical Research Center of Cardiology, The Ministry of Health of the Russian Federation, Moscow, Russia.; Department of Medical Nanobiotechnology, Institute of Translational Medicine, N.I. Pirogov Russian National Research Medical University, The Ministry of Health of the Russian Federation, Moscow, Russia., Chekhonin VP; Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Moscow, Russia.; Department of Medical Nanobiotechnology, Institute of Translational Medicine, N.I. Pirogov Russian National Research Medical University, The Ministry of Health of the Russian Federation, Moscow, Russia.
المصدر: Frontiers in pharmacology [Front Pharmacol] 2022 Jan 10; Vol. 12, pp. 777628. Date of Electronic Publication: 2022 Jan 10 (Print Publication: 2021).
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [Lausanne : Frontiers Media]
مستخلص: The regeneration of nerve tissue after spinal cord injury is a complex and poorly understood process. Medication and surgery are not very effective treatments for patients with spinal cord injuries. Gene therapy is a popular approach for the treatment of such patients. The delivery of therapeutic genes is carried out in a variety of ways, such as direct injection of therapeutic vectors at the site of injury, retrograde delivery of vectors, and ex vivo therapy using various cells. Recombinant adenoviruses are often used as vectors for gene transfer. This review discusses the advantages, limitations and prospects of adenovectors in spinal cord injury therapy.
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2022 Sosnovtseva, Stepanova, Stepanenko, Voronova, Chadin, Valikhov and Chekhonin.)
References: Crit Care Med. 2010 Nov;38(11):2181-9. (PMID: 20711072)
Mol Ther. 2007 Dec;15(12):2154-63. (PMID: 17895861)
Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2199-204. (PMID: 11854516)
J Med Virol. 2012 Sep;84(9):1408-14. (PMID: 22825819)
PLoS One. 2012;7(2):e31061. (PMID: 22347429)
Annu Rev Neurosci. 2007;30:399-423. (PMID: 17378766)
J Neurosci Res. 2006 Aug 15;84(3):553-67. (PMID: 16786574)
J Neurosci. 2009 Nov 25;29(47):14932-41. (PMID: 19940189)
Brain Res Bull. 2017 Jun;132:44-52. (PMID: 28529158)
Gene Ther. 2005 Oct;12 Suppl 1:S18-27. (PMID: 16231052)
Gene Ther. 2009 Feb;16(2):262-78. (PMID: 19078993)
J Neurosci. 2007 Sep 5;27(36):9545-59. (PMID: 17804616)
Neural Regen Res. 2015 May;10(5):726-42. (PMID: 26109946)
Cell Biol Int. 2009 Apr;33(4):466-74. (PMID: 18725309)
J Virol. 2002 May;76(9):4580-90. (PMID: 11932423)
Gene Ther. 2000 Oct;7(20):1707-14. (PMID: 11083491)
Neurosci Lett. 2005 Sep 2;385(1):30-5. (PMID: 15936879)
J Neurotrauma. 2015 Mar 15;32(6):367-80. (PMID: 25203134)
J Neurotrauma. 2006 Mar-Apr;23(3-4):508-20. (PMID: 16629633)
J Neurobiol. 1997 Aug;33(2):172-84. (PMID: 9240373)
Eur Spine J. 2007 Dec;16(12):2206-14. (PMID: 17885772)
Exp Neurol. 2007 Oct;207(2):203-17. (PMID: 17719577)
Exp Neurol. 2016 Apr;278:27-41. (PMID: 26828688)
Spine (Phila Pa 1976). 2012 Dec 15;37(26):2125-35. (PMID: 22648027)
World Neurosurg. 2014 Nov;82(5):848-54. (PMID: 23454689)
J Neurosci. 2000 Jun 15;20(12):4435-45. (PMID: 10844012)
Spine (Phila Pa 1976). 2010 Mar 1;35(5):497-504. (PMID: 20190624)
Neurosurgery. 2006 Nov;59(5):957-82; discussion 982-7. (PMID: 17143232)
Gene Ther. 2002 Jan;9(2):135-46. (PMID: 11857072)
Curr Opin Drug Discov Devel. 2006 Sep;9(5):580-6. (PMID: 17002218)
Exp Hematol. 2000 Apr;28(4):382-90. (PMID: 10781896)
Acta Neurochir (Wien). 2016 Feb;158(2):367-78. (PMID: 26592254)
Neurosci Lett. 2017 Mar 16;643:111-120. (PMID: 28215880)
Hematol Oncol. 2006 Sep;24(3):151-8. (PMID: 16700092)
J Neurotrauma. 2011 Apr;28(4):635-47. (PMID: 21299337)
Handb Exp Pharmacol. 2014;220:443-60. (PMID: 24668482)
Hum Gene Ther. 2002 Jul 20;13(11):1337-47. (PMID: 12162816)
Mol Cells. 2017 Aug;40(8):598-605. (PMID: 28835020)
J Neurosci. 2003 Feb 15;23(4):1424-31. (PMID: 12598631)
Neuroscience. 2012 Jan 3;200:19-30. (PMID: 22100785)
Neuroscience. 2014 Aug 22;274:318-30. (PMID: 24892760)
J Neurotrauma. 2004 Mar;21(3):329-37. (PMID: 15115607)
PLoS One. 2017 Dec 21;12(12):e0190125. (PMID: 29267342)
J Vis Exp. 2015 Jul 13;(101):e52846. (PMID: 26273739)
Front Neurol. 2013 Nov 19;4:187. (PMID: 24312075)
Brain Res. 2010 Nov 4;1359:256-71. (PMID: 20816761)
Eur J Neurosci. 2000 Sep;12(9):3437-42. (PMID: 10998127)
Cytotherapy. 2010 Oct;12(6):792-806. (PMID: 20524772)
Gene Ther. 2003 Jul;10(14):1135-41. (PMID: 12833122)
Spinal Cord. 2016 May;54(5):347-59. (PMID: 26415641)
Neurosci Lett. 2006 Nov 13;408(2):98-103. (PMID: 16996685)
Virus Res. 2005 Dec;114(1-2):45-53. (PMID: 15996786)
Microvasc Res. 2008 Jan;75(1):83-90. (PMID: 17603084)
J Neurosci. 2006 Mar 29;26(13):3377-89. (PMID: 16571744)
Mol Ther. 2003 Mar;7(3):354-65. (PMID: 12668131)
Exp Neurol. 2000 Nov;166(1):115-26. (PMID: 11031088)
Mol Ther. 2009 Feb;17(2):327-33. (PMID: 19050700)
Rev Neurosci. 2004;15(2):117-29. (PMID: 15202684)
J Neurosci Res. 2003 Oct 15;74(2):221-6. (PMID: 14515351)
Stem Cells. 2005 Nov-Dec;23(10):1598-607. (PMID: 16293583)
Stem Cell Res Ther. 2019 Apr 3;10(1):115. (PMID: 30944028)
J Neurotrauma. 2007 Dec;24(12):1863-77. (PMID: 18159998)
Genes Dis. 2017 Jun;4(2):43-63. (PMID: 28944281)
Ann Neurol. 1995 Sep;38(3):429-36. (PMID: 7668829)
Exp Cell Res. 2002 Sep 10;279(1):34-9. (PMID: 12213211)
Exp Neurol. 2014 Nov;261:308-19. (PMID: 24873728)
Spinal Cord. 2007 Jan;45(1):15-24. (PMID: 16773039)
Biochem Biophys Res Commun. 2005 Mar 25;328(4):1182-7. (PMID: 15708001)
Nat Rev Neurosci. 2004 Feb;5(2):146-56. (PMID: 14735117)
Neuroreport. 2004 Mar 1;15(3):425-9. (PMID: 15094497)
Oncotarget. 2017 Oct 24;8(56):96276-96289. (PMID: 29221205)
J Physiol. 2001 May 15;533(Pt 1):83-9. (PMID: 11351016)
Stem Cells. 2004;22(7):1279-91. (PMID: 15579646)
Exp Neurol. 2003 Jun;181(2):115-29. (PMID: 12781986)
Neural Regen Res. 2016 May;11(5):743-4. (PMID: 27335556)
J Neurosci. 2007 Sep 26;27(39):10535-45. (PMID: 17898225)
Stem Cells Dev. 2019 Sep 15;28(18):1253-1263. (PMID: 31310179)
Gene Ther. 2010 Aug;17(8):1052-61. (PMID: 20485381)
Appl Biochem Biotechnol. 2006 Apr;133(1):9-29. (PMID: 16622281)
Front Neurol. 2013 May 20;4:58. (PMID: 23730296)
Biomaterials. 2011 Oct;32(30):7454-68. (PMID: 21783247)
Hum Gene Ther. 1997 Jun 10;8(9):1049-63. (PMID: 9189763)
Nat Med. 2004 Jun;10(6):610-6. (PMID: 15156204)
Mol Med Rep. 2019 Sep;20(3):2763-2773. (PMID: 31322240)
Neurosci Lett. 2017 Mar 22;644:67-75. (PMID: 28213069)
Exp Hematol. 2005 Aug;33(8):865-72. (PMID: 16038778)
Hum Gene Ther. 2004 Dec;15(12):1157-66. (PMID: 15684693)
J Neurotrauma. 2007 Apr;24(4):703-12. (PMID: 17439352)
Virol J. 2010 Jul 08;7:148. (PMID: 20615244)
Glia. 1999 Jan 15;25(2):165-78. (PMID: 9890631)
Brain Res Bull. 1998 Sep 15;47(2):133-40. (PMID: 9820730)
Cell Transplant. 2017 Aug;26(8):1472-1482. (PMID: 28901182)
PLoS One. 2013 Apr 24;8(4):e62860. (PMID: 23638158)
Glia. 2007 Jul;55(9):976-1000. (PMID: 17526000)
Int J Mol Sci. 2020 May 21;21(10):. (PMID: 32455640)
J Neurol Sci. 2009 Oct 15;285(1-2):67-77. (PMID: 19555980)
Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13174-9. (PMID: 16938843)
Clin Diagn Lab Immunol. 2004 Mar;11(2):351-7. (PMID: 15013987)
J Orthop Sci. 2006 Jan;11(1):64-9. (PMID: 16437351)
Prog Brain Res. 2004;146:451-76. (PMID: 14699980)
Neurobiol Dis. 2010 Feb;37(2):384-93. (PMID: 19879362)
Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):3930-5. (PMID: 15753292)
Hum Gene Ther. 2014 Jan;25(1):3-11. (PMID: 24444179)
Exp Neurol. 1998 Sep;153(1):102-12. (PMID: 9743571)
Cell Transplant. 2016;25(8):1425-38. (PMID: 26850705)
Exp Neurobiol. 2019 Dec 31;28(6):679-696. (PMID: 31902156)
Philos Trans R Soc Lond B Biol Sci. 2006 Sep 29;361(1473):1611-34. (PMID: 16939978)
J Neurosci. 2003 Aug 6;23(18):7045-58. (PMID: 12904465)
J Neurosurg Spine. 2017 Jul;27(1):105-115. (PMID: 28452633)
J Neurotrauma. 2010 May;27(5):789-801. (PMID: 20144012)
Cell Transplant. 2000 Mar-Apr;9(2):169-78. (PMID: 10811391)
Tissue Eng Part A. 2008 May;14(5):681-90. (PMID: 18402551)
J Neurosci Res. 2008 Jun;86(8):1789-800. (PMID: 18253945)
Exp Neurol. 2003 Oct;183(2):508-15. (PMID: 14552891)
Mol Biol Rep. 2012 Aug;39(8):8045-51. (PMID: 22531936)
Brain Res. 1997 Sep 12;768(1-2):19-29. (PMID: 9369296)
فهرسة مساهمة: Keywords: brain-derived neurotrophic factor (BDNF); glial cell derived neurotrophic factor (GDNF); neurotrophin 3 (NT3); recombinant adenovirus; spinal cord injury (SCI)
تواريخ الأحداث: Date Created: 20220127 Latest Revision: 20220128
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC8784517
DOI: 10.3389/fphar.2021.777628
PMID: 35082666
قاعدة البيانات: MEDLINE
الوصف
تدمد:1663-9812
DOI:10.3389/fphar.2021.777628